SPONTANEOUS BREATH THROUGH DIFFERENT EXTRATRACHEAL AIRWAYS DURING DEEP SEDATION

1998 ◽  
Vol 89 (Supplement) ◽  
pp. 567A
Author(s):  
A Casati ◽  
G Fanelli ◽  
E Casaletti ◽  
G Aldegheri ◽  
M Berti ◽  
...  
2007 ◽  
Vol 35 (9) ◽  
pp. 17
Author(s):  
ROBERT FINN
Keyword(s):  

2020 ◽  
Author(s):  
L Medina-Prado ◽  
JM Sempere ◽  
S Baile-Maxía ◽  
M Bozhychko ◽  
C Mangas-Sanjuán ◽  
...  
Keyword(s):  

2019 ◽  
Vol 06 (02) ◽  
pp. 056-061 ◽  
Author(s):  
Nieves Vanaclocha ◽  
Vicente Chisbert ◽  
Vicent Quilis ◽  
Federico Bilotta ◽  
Rafael Badenes

AbstractSedation is an essential therapeutic strategy in the care of neurocritical patients. Intravenous sedative agents are the most widely used, with promising alternatives (dexmedetomidine, ketamine, and volatile agents) to propofol and midazolam arising. Studies designed to evaluate superiority and avoid biases are required. A neurological awakening test is safe in most patients. Potential risks and benefits of limiting deep sedation and daily interruption of sedation in these patients remain unclear. The aim of this review was to report recent clinical evidence on sedation in this subgroup of patients, focusing on its effects on clinical prognosis.


2018 ◽  
Vol 88 (3) ◽  
Author(s):  
Sergio C. Conte ◽  
Giulia Spagnol ◽  
Marco Confalonieri ◽  
Beatrice Brizi

The sedation plays an important role in the endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) procedure. The sedation can be Minimal (anxiolysis), Moderate (conscious sedation) or Deep. The ACCP guidelines suggest that moderate or deep sedation (DS) is an acceptable approach. In fact, several studies compare moderate versus deep sedation, but no study has been carried out to compare deep sedation versus minimal. We carried out a retrospective study to compare the Deep versus Minimal sedation (MiS) in patients undergoing EBUS-TBNA.  The primary end point was the diagnostic accuracy. The secondary end points were adequacy and sensitivity. We evaluated the LN size sampling, procedural time, complications and patient tolerance. Thirty-six patients underwent EBUS-TBNA, 16 under DS and 20 under MiS. The overall diagnostic accuracy for correct diagnosis was 92.9% in DS group and 94.1% in MiS group (p=0.554). Sample adequacy, defined as the percentage of patients with a specific diagnosis by EBUS-TBNA, was 87.5% (14 of 16) and 85% (17 of 20) for the DS group and MiS group, respectively, (p=0.788); the sensitivity was 92.9% in the DS group (95% CI, 73-100%) and 92.9% in the MiS group (95% CI, 77-100%) (p=0.463). There were no major complications in either group. Minor complications were 4 in MiS and 1 in DS (p=0.355).  The patients in the MiS group recalled the procedure more often compared to the other group (p=0.041). The majority of the patients would agree to undergo the same procedure again in the future in both groups (p=0.766).  In our experience EBUS-TBNA performed under MiS has comparable accuracy, adequacy, sensitivity, complications and patient satisfaction to DS, even if the sample was small.  Future prospective multicenter studies are needed to confirm our results.


Sign in / Sign up

Export Citation Format

Share Document